Literature DB >> 30694691

Lipid and glucose metabolism in hepatocyte cell lines and primary mouse hepatocytes: a comprehensive resource for in vitro studies of hepatic metabolism.

Shilpa R Nagarajan1, Moumita Paul-Heng2, James R Krycer3, Daniel J Fazakerley3, Alexandra F Sharland2, Andrew J Hoy1.   

Abstract

The liver is a critical tissue for maintaining glucose, fatty acid, and cholesterol homeostasis. Primary hepatocytes represent the gold standard for studying the mechanisms controlling hepatic glucose, lipid, and cholesterol metabolism in vitro. However, access to primary hepatocytes can be limiting, and therefore, other immortalized hepatocyte models are commonly used. Here, we describe substrate metabolism of cultured AML12, IHH, and PH5CH8 cells, hepatocellular carcinoma-derived HepG2s, and primary mouse hepatocytes (PMH) to identify which of these cell lines most accurately phenocopy PMH basal and insulin-stimulated metabolism. Insulin-stimulated glucose metabolism in PH5CH8 cells, and to a lesser extent AML12 cells, responded most similarly to PMH. Notably, glucose incorporation in HepG2 cells were 14-fold greater than PMH. The differences in glucose metabolic activity were not explained by differential protein expression of key regulators of these pathways, for example glycogen synthase and glycogen content. In contrast, fatty acid metabolism in IHH cells was the closest to PMHs, yet insulin-responsive fatty acid metabolism in AML12 and HepG2 cells was most similar to PMH. Finally, incorporation of acetate into intracellular-free cholesterol was comparable for all cells to PMH; however, insulin-stimulated glucose conversion into lipids and the incorporation of acetate into intracellular cholesterol esters were strikingly different between PMHs and all tested cell lines. In general, AML12 cells most closely phenocopied PMH in vitro energy metabolism. However, the cell line most representative of PMHs differed depending on the mode of metabolism being investigated, and so careful consideration is needed in model selection.

Entities:  

Keywords:  cell lines; fatty acid metabolism; glucose metabolism; insulin action; protein expression

Mesh:

Substances:

Year:  2019        PMID: 30694691     DOI: 10.1152/ajpendo.00365.2018

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  16 in total

1.  Remodeling of Hepatocyte Mitochondrial Metabolism and De Novo Lipogenesis During the Embryonic-to-Neonatal Transition in Chickens.

Authors:  Chaitra Surugihalli; Linda S Farley; Ronique C Beckford; Boonyarit Kamkrathok; Hsiao-Ching Liu; Vaishna Muralidaran; Kruti Patel; Tom E Porter; Nishanth E Sunny
Journal:  Front Physiol       Date:  2022-04-21       Impact factor: 4.755

2.  Dynamic 3D genome reorganization during development and metabolic stress of the porcine liver.

Authors:  Luxi Chen; Jing Li; Renqiang Yuan; Yujie Wang; Jiaman Zhang; Yu Lin; Lina Wang; Xingxing Zhu; Wei Zhu; Jingyi Bai; Fanli Kong; Bo Zeng; Lu Lu; Jideng Ma; Keren Long; Long Jin; Zhiqing Huang; Jinlong Huo; Yiren Gu; Danyang Wang; Delin Mo; Diyan Li; Qianzi Tang; Xuewei Li; Jiangwei Wu; Yaosheng Chen; Mingzhou Li
Journal:  Cell Discov       Date:  2022-06-14       Impact factor: 38.079

3.  Liver-specific deletion of IGF2 mRNA binding protein-2/IMP2 reduces hepatic fatty acid oxidation and increases hepatic triglyceride accumulation.

Authors:  Laura Regué; Liliana Minichiello; Joseph Avruch; Ning Dai
Journal:  J Biol Chem       Date:  2019-06-17       Impact factor: 5.157

Review 4.  Non-alcoholic Fatty Liver Disease as a Canonical Example of Metabolic Inflammatory-Based Liver Disease Showing a Sex-Specific Prevalence: Relevance of Estrogen Signaling.

Authors:  Sara Della Torre
Journal:  Front Endocrinol (Lausanne)       Date:  2020-09-18       Impact factor: 5.555

Review 5.  Lipid composition of the cancer cell membrane.

Authors:  Wojciech Szlasa; Iga Zendran; Aleksandra Zalesińska; Mounir Tarek; Julita Kulbacka
Journal:  J Bioenerg Biomembr       Date:  2020-07-26       Impact factor: 2.945

6.  TMAO-Activated Hepatocyte-Derived Exosomes Impair Angiogenesis via Repressing CXCR4.

Authors:  Xiang Liu; Yijia Shao; Jiazichao Tu; Jiapan Sun; Bing Dong; Zhichao Wang; Jianrong Zhou; Long Chen; Jun Tao; Jimei Chen
Journal:  Front Cell Dev Biol       Date:  2022-01-31

7.  Trimethylamine-N-oxide-stimulated hepatocyte-derived exosomes promote inflammation and endothelial dysfunction through nuclear factor-kappa B signaling.

Authors:  Xiang Liu; Yijia Shao; Jiazichao Tu; Jiapan Sun; Lifu Li; Jun Tao; Jimei Chen
Journal:  Ann Transl Med       Date:  2021-11

Review 8.  The Combination of Cell Cultured Technology and In Silico Model to Inform the Drug Development.

Authors:  Zhengying Zhou; Jinwei Zhu; Muhan Jiang; Lan Sang; Kun Hao; Hua He
Journal:  Pharmaceutics       Date:  2021-05-12       Impact factor: 6.321

9.  Insulin signaling and glucose metabolism in different hepatoma cell lines deviate from hepatocyte physiology toward a convergent aberrant phenotype.

Authors:  Angela Molinaro; Barbara Becattini; Giovanni Solinas
Journal:  Sci Rep       Date:  2020-07-21       Impact factor: 4.379

Review 10.  Application of In Vitro Metabolism Activation in High-Throughput Screening.

Authors:  Masato Ooka; Caitlin Lynch; Menghang Xia
Journal:  Int J Mol Sci       Date:  2020-10-31       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.